MYCN and neuroblastoma: Therefore, it is likely that both mitotic arrest and loss of p4E-BP1-mediated cap-dependent protein translation contribute to the loss of MCL-1 following MLN8237 treatment in MYCN-amplified neuroblastoma cells.